IP45-02: Direct pharmacological targeting of ß-catenin by artesunate: a novel therapeutic approach for ureteral fibrosis
Saturday, May 16, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
146B
Abstract
See all the content and easy-to-use features by logging in or registering!